Ann: Notice to option holders - Entitlements Issue, page-4

First 4 Last

Share
Profile

Follow
Merchant2000

21,658 Posts.

886

28/03/19

11:07

Post #: 37911513
Share

Originally posted by Saltiga62: ↑

So Quoted
A prospectus containing information in respect of the Entitlement Offer (Prospectus) will be sent to Eligible Shareholders by
Friday, 5 April 2019 and will be made available on the Company’s website www.orinocogold.com.
The contents of Orinoco's website do not form part of the offer document for the Entitlement Offer.
Eligible Shareholders should read the Prospectus in full in deciding whether to subscribe for Shares or sell their Entitlement.
YET WE CAN'T CAN WE ? AS PROSPECTUS IS BEING SENT OUT 4 DAY'S AFTER RIGHTS START TRADING ?Any Eligible Shareholder who wishes to acquire Shares under the Entitlement Offer will need to complete, or otherwise apply in accordance
with, the personalised entitlement and acceptance form that will accompany the Prospectus.

Note 5th AprilSo we as share holders should read the prospectus FIRST -though not sent out until the 5th of April .To acquire Shares under the Entitlement Offer share holders will need to complete the personalised entitlement and
acceptance form that will accompany the Prospectus.

Yet Indicative time table.
Rights start trading 01 April ?
Yet this is before we have received or read the Prospectus-not sent out until the 5th of April ?
And in addition we can't have filled out the personalised entitlement and acceptance form that will accompany
the Prospectus by the time rights start trading on Monday the 1st as we haven received the form that will be sent 4 days latter ?salt

Expand

Salt,

Whats your opinion on the:

6% underwriters fee on total raise amount
6% managers fee on total raise amount
$150k success fee
S10k per month advisory fee for 12 months
400 million options at .4c with 3 year expiry to Empire Capital

DYOR

OGX Price at posting: 0.4¢ Sentiment: None Disclosure: Not Held
2 Upvote

2 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 11 more messages in this thread...

First 4 Last

Add OGX (ASX) to my watchlist

Ann: Notice to option holders - Entitlements Issue, page-4

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News